NEW YORK (GenomeWeb) – Puma Biotechnology and Strata Oncology said today that they have entered a collaboration aimed at accelerating patient enrollment in Puma's ongoing Phase II SUMMIT trial of PB272 (neratinib).

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.